London, UK – June 12, 2019.
At the recent AI Summit held during London's Tech week,
Google, Indegene and Microsoft came together in a joint panel
moderated by Pfizer to discuss
How AI is transforming clinical and commercial operations
in life sciences
. The panel covered a number of Artificial Intelligence (AI)
use cases for real world data (RWD) in commercial and patient
empowerment, and for the optimization of clinical trial
operations. Discussions also focused on present as well as
future advances in the patient journey, inclusive of examples
of preventive medicine that will undoubtedly shape the future
state of medicine.
The innovations highlighted included the Moorfields Eye
Hospital and DeepMind project where machine learning has been
applied to 1 million anonymous eye scans to help identify
early signs of eye conditions that humans might miss in the
diagnosis process. DeepMind, acquired by Google in 2014,
published the project in late 2018. Considering that 98% of
vision loss resulting from diabetes is preventable through
early detection, and that in the UK alone, 2 million people
live with vision loss, a more intelligent and reliable
diagnostic solution needed to be discovered.1
Microsoft highlighted its project with NHS Glasgow and Clyde
where tracking of patient data from various sources, such as
Chronic Obstructive Pulmonary Disease (COPD) symptom diaries,
and activity monitors allow the NHS to predict flare-ups in
order to help reduce patient intake at hospital emergency
centres and treat patients with COPD in earlier stages of the
disease.2 Finally,
Indegene's AI use case focused on the R&D and clinical and
medical business side of life sciences, looking at how AI can
help biopharma companies reuse content by auto-creating and
updating medical documents. The AI use case highlighted the
incubation initiative with Pfizer, to create an integrated
content model of interrelated clinical, regulatory, safety and
medical documents, leveraging Indegene's Intelligent Content
Platform to systematically and holistically determine what
content or documents could be auto-generated and what content
could be meaningfully reused. Dr Sian Ratcliffe, Head of
Medical Writing at Pfizer, and the panel moderator at the AI
summit highlighted
These types of efficiencies are critically important in
generating high quality clinical documents to support
approval of our medicines, so that we can fulfill our
purpose of bringing new breakthroughs that change patients'
lives more quickly than ever before.
For more information, contact colleen.youngblood@indegene.com
About Indegene
Indegene ( www.indegene.com) enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations and medical expertise and drives better health and business outcomes. Indegene's IP-based solutions help clients drive revenues and productivity by making transformational leaps in digitalization of customer engagement, health reform, healthcare cost reduction and health outcomes improvement.
References
1. DeepMind. Moorfields Eye Hospital NHS Foundation Trust. DeepMind Website: https://deepmind.com/applied/deepmind-health/working-partners/health-research-tomorrow/moorfields-eye-hospital-nhs-foundation-trust/. Accessed June 21, 2019.
2. Microsoft. NHS Glasgow & Clyde uses Microsoft Artificial Intelligence to transform care for patients. Microsoft Website: https://customers.microsoft.com/en-us/story/nhs-glasgow-clyde-uses-microsoft-ai/. Accessed June 21, 2019.
